Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:therapy responder'
(id=6821389 ; fe=en:therapy responder ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=4245 creation date=2017-06-25 touchdate=2025-07-25 10:44:11.000)
≈ 72 relations sortantes

  1. en:therapy responder -- r_associated #0: 42 / 1 -> en:increased drug tolerance
    n1=en:therapy responder | n2=en:increased drug tolerance | rel=r_associated | relid=0 | w=42
  2. en:therapy responder -- r_associated #0: 41 / 0.976 -> en:drug effect incomplete
    n1=en:therapy responder | n2=en:drug effect incomplete | rel=r_associated | relid=0 | w=41
  3. en:therapy responder -- r_associated #0: 40 / 0.952 -> en:drug action prolonged
    n1=en:therapy responder | n2=en:drug action prolonged | rel=r_associated | relid=0 | w=40
  4. en:therapy responder -- r_associated #0: 40 / 0.952 -> en:therapy non-responder
    n1=en:therapy responder | n2=en:therapy non-responder | rel=r_associated | relid=0 | w=40
  5. en:therapy responder -- r_associated #0: 37 / 0.881 -> en:enzyme inhibition disorder
    n1=en:therapy responder | n2=en:enzyme inhibition disorder | rel=r_associated | relid=0 | w=37
  6. en:therapy responder -- r_associated #0: 37 / 0.881 -> répondeur au traitement
    n1=en:therapy responder | n2=répondeur au traitement | rel=r_associated | relid=0 | w=37
  7. en:therapy responder -- r_associated #0: 36 / 0.857 -> en:effect, sympathomimetic
    n1=en:therapy responder | n2=en:effect, sympathomimetic | rel=r_associated | relid=0 | w=36
  8. en:therapy responder -- r_associated #0: 35 / 0.833 -> en:fishbane reaction
    n1=en:therapy responder | n2=en:fishbane reaction | rel=r_associated | relid=0 | w=35
  9. en:therapy responder -- r_associated #0: 35 / 0.833 -> en:remission not achieved
    n1=en:therapy responder | n2=en:remission not achieved | rel=r_associated | relid=0 | w=35
  10. en:therapy responder -- r_associated #0: 35 / 0.833 -> en:shortened therapeutic response
    n1=en:therapy responder | n2=en:shortened therapeutic response | rel=r_associated | relid=0 | w=35
  11. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:adverse reaction
    n1=en:therapy responder | n2=en:adverse reaction | rel=r_associated | relid=0 | w=34
  12. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:drug effect delayed
    n1=en:therapy responder | n2=en:drug effect delayed | rel=r_associated | relid=0 | w=34
  13. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:drug effect faster than expected
    n1=en:therapy responder | n2=en:drug effect faster than expected | rel=r_associated | relid=0 | w=34
  14. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:drug intolerance
    n1=en:therapy responder | n2=en:drug intolerance | rel=r_associated | relid=0 | w=34
  15. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:multidrug resistance process
    n1=en:therapy responder | n2=en:multidrug resistance process | rel=r_associated | relid=0 | w=34
  16. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:negative cardiac inotropic effect
    n1=en:therapy responder | n2=en:negative cardiac inotropic effect | rel=r_associated | relid=0 | w=34
  17. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:prolonged therapeutic response
    n1=en:therapy responder | n2=en:prolonged therapeutic response | rel=r_associated | relid=0 | w=34
  18. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:reaction time decreased
    n1=en:therapy responder | n2=en:reaction time decreased | rel=r_associated | relid=0 | w=34
  19. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:renin-angiotensin system inhibition
    n1=en:therapy responder | n2=en:renin-angiotensin system inhibition | rel=r_associated | relid=0 | w=34
  20. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:therapeutic and nontherapeutic responses
    n1=en:therapy responder | n2=en:therapeutic and nontherapeutic responses | rel=r_associated | relid=0 | w=34
  21. en:therapy responder -- r_associated #0: 34 / 0.81 -> en:therapeutic response unexpected
    n1=en:therapy responder | n2=en:therapeutic response unexpected | rel=r_associated | relid=0 | w=34
  22. en:therapy responder -- r_associated #0: 32 / 0.762 -> en:adverse event
    n1=en:therapy responder | n2=en:adverse event | rel=r_associated | relid=0 | w=32
  23. en:therapy responder -- r_associated #0: 32 / 0.762 -> en:decreased therapeutic response
    n1=en:therapy responder | n2=en:decreased therapeutic response | rel=r_associated | relid=0 | w=32
  24. en:therapy responder -- r_associated #0: 32 / 0.762 -> en:diet failure
    n1=en:therapy responder | n2=en:diet failure | rel=r_associated | relid=0 | w=32
  25. en:therapy responder -- r_associated #0: 32 / 0.762 -> en:immediate post-injection reaction
    n1=en:therapy responder | n2=en:immediate post-injection reaction | rel=r_associated | relid=0 | w=32
  26. en:therapy responder -- r_associated #0: 32 / 0.762 -> en:increased therapeutic response
    n1=en:therapy responder | n2=en:increased therapeutic response | rel=r_associated | relid=0 | w=32
  27. en:therapy responder -- r_associated #0: 32 / 0.762 -> en:similar reaction on previous exposure to drug
    n1=en:therapy responder | n2=en:similar reaction on previous exposure to drug | rel=r_associated | relid=0 | w=32
  28. en:therapy responder -- r_associated #0: 31 / 0.738 -> en:drug tolerance
    n1=en:therapy responder | n2=en:drug tolerance | rel=r_associated | relid=0 | w=31
  29. en:therapy responder -- r_associated #0: 31 / 0.738 -> en:idiosyncratic drug effect
    n1=en:therapy responder | n2=en:idiosyncratic drug effect | rel=r_associated | relid=0 | w=31
  30. en:therapy responder -- r_associated #0: 31 / 0.738 -> en:surgical failure
    n1=en:therapy responder | n2=en:surgical failure | rel=r_associated | relid=0 | w=31
  31. en:therapy responder -- r_associated #0: 31 / 0.738 -> en:therapeutic product ineffective
    n1=en:therapy responder | n2=en:therapeutic product ineffective | rel=r_associated | relid=0 | w=31
  32. en:therapy responder -- r_associated #0: 31 / 0.738 -> en:treatment failure
    n1=en:therapy responder | n2=en:treatment failure | rel=r_associated | relid=0 | w=31
  33. en:therapy responder -- r_associated #0: 30 / 0.714 -> effet indésirable d'un médicament
    n1=en:therapy responder | n2=effet indésirable d'un médicament | rel=r_associated | relid=0 | w=30
  34. en:therapy responder -- r_associated #0: 30 / 0.714 -> en:adverse reaction to drug
    n1=en:therapy responder | n2=en:adverse reaction to drug | rel=r_associated | relid=0 | w=30
  35. en:therapy responder -- r_associated #0: 30 / 0.714 -> en:drug ineffective for unapproved indication
    n1=en:therapy responder | n2=en:drug ineffective for unapproved indication | rel=r_associated | relid=0 | w=30
  36. en:therapy responder -- r_associated #0: 30 / 0.714 -> en:drug resistance process
    n1=en:therapy responder | n2=en:drug resistance process | rel=r_associated | relid=0 | w=30
  37. en:therapy responder -- r_associated #0: 30 / 0.714 -> en:reactogenicity event
    n1=en:therapy responder | n2=en:reactogenicity event | rel=r_associated | relid=0 | w=30
  38. en:therapy responder -- r_associated #0: 30 / 0.714 -> en:vaccine positive rechallenge
    n1=en:therapy responder | n2=en:vaccine positive rechallenge | rel=r_associated | relid=0 | w=30
  39. en:therapy responder -- r_associated #0: 30 / 0.714 -> en:virologic failure
    n1=en:therapy responder | n2=en:virologic failure | rel=r_associated | relid=0 | w=30
  40. en:therapy responder -- r_associated #0: 29 / 0.69 -> en:adverse event following immunization
    n1=en:therapy responder | n2=en:adverse event following immunization | rel=r_associated | relid=0 | w=29
  41. en:therapy responder -- r_associated #0: 29 / 0.69 -> en:dermal absorption impaired
    n1=en:therapy responder | n2=en:dermal absorption impaired | rel=r_associated | relid=0 | w=29
  42. en:therapy responder -- r_associated #0: 29 / 0.69 -> en:drug ineffective
    n1=en:therapy responder | n2=en:drug ineffective | rel=r_associated | relid=0 | w=29
  43. en:therapy responder -- r_associated #0: 29 / 0.69 -> en:insulin sparing effect
    n1=en:therapy responder | n2=en:insulin sparing effect | rel=r_associated | relid=0 | w=29
  44. en:therapy responder -- r_associated #0: 29 / 0.69 -> en:paradoxical drug reaction
    n1=en:therapy responder | n2=en:paradoxical drug reaction | rel=r_associated | relid=0 | w=29
  45. en:therapy responder -- r_associated #0: 29 / 0.69 -> en:positive cardiac inotropic effect
    n1=en:therapy responder | n2=en:positive cardiac inotropic effect | rel=r_associated | relid=0 | w=29
  46. en:therapy responder -- r_associated #0: 29 / 0.69 -> en:therapeutic product ineffective for unapproved indication
    n1=en:therapy responder | n2=en:therapeutic product ineffective for unapproved indication | rel=r_associated | relid=0 | w=29
  47. en:therapy responder -- r_associated #0: 28 / 0.667 -> en:adverse reaction to food
    n1=en:therapy responder | n2=en:adverse reaction to food | rel=r_associated | relid=0 | w=28
  48. en:therapy responder -- r_associated #0: 28 / 0.667 -> en:decreased drug tolerance
    n1=en:therapy responder | n2=en:decreased drug tolerance | rel=r_associated | relid=0 | w=28
  49. en:therapy responder -- r_associated #0: 28 / 0.667 -> en:dermal absorption increased
    n1=en:therapy responder | n2=en:dermal absorption increased | rel=r_associated | relid=0 | w=28
  50. en:therapy responder -- r_associated #0: 28 / 0.667 -> en:drug action increased
    n1=en:therapy responder | n2=en:drug action increased | rel=r_associated | relid=0 | w=28
  51. en:therapy responder -- r_associated #0: 28 / 0.667 -> en:drug effect variable
    n1=en:therapy responder | n2=en:drug effect variable | rel=r_associated | relid=0 | w=28
  52. en:therapy responder -- r_associated #0: 28 / 0.667 -> en:no reaction on previous exposure to drug
    n1=en:therapy responder | n2=en:no reaction on previous exposure to drug | rel=r_associated | relid=0 | w=28
  53. en:therapy responder -- r_associated #0: 28 / 0.667 -> en:therapeutic response changed
    n1=en:therapy responder | n2=en:therapeutic response changed | rel=r_associated | relid=0 | w=28
  54. en:therapy responder -- r_associated #0: 27 / 0.643 -> en:enzyme induction
    n1=en:therapy responder | n2=en:enzyme induction | rel=r_associated | relid=0 | w=27
  55. en:therapy responder -- r_associated #0: 27 / 0.643 -> en:tachyphylaxis
    n1=en:therapy responder | n2=en:tachyphylaxis | rel=r_associated | relid=0 | w=27
  56. en:therapy responder -- r_associated #0: 27 / 0.643 -> thérapie
    n1=en:therapy responder | n2=thérapie | rel=r_associated | relid=0 | w=27
  57. en:therapy responder -- r_associated #0: 26 / 0.619 -> en:drug action decreased
    n1=en:therapy responder | n2=en:drug action decreased | rel=r_associated | relid=0 | w=26
  58. en:therapy responder -- r_associated #0: 26 / 0.619 -> en:drug cross-reactivity
    n1=en:therapy responder | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  59. en:therapy responder -- r_associated #0: 26 / 0.619 -> en:no prior therapy
    n1=en:therapy responder | n2=en:no prior therapy | rel=r_associated | relid=0 | w=26
  60. en:therapy responder -- r_associated #0: 26 / 0.619 -> en:therapeutic response delayed
    n1=en:therapy responder | n2=en:therapeutic response delayed | rel=r_associated | relid=0 | w=26
  61. en:therapy responder -- r_associated #0: 26 / 0.619 -> en:therapy partial responder
    n1=en:therapy responder | n2=en:therapy partial responder | rel=r_associated | relid=0 | w=26
  62. en:therapy responder -- r_associated #0: 26 / 0.619 -> réaction indésirable
    n1=en:therapy responder | n2=réaction indésirable | rel=r_associated | relid=0 | w=26
  63. en:therapy responder -- r_associated #0: 25 / 0.595 -> en:therapy
    n1=en:therapy responder | n2=en:therapy | rel=r_associated | relid=0 | w=25
  64. en:therapy responder -- r_associated #0: 20 / 0.476 -> Besredka (méthode de)
    n1=en:therapy responder | n2=Besredka (méthode de) | rel=r_associated | relid=0 | w=20
  65. en:therapy responder -- r_associated #0: 20 / 0.476 -> en:atypical dose response relationship
    n1=en:therapy responder | n2=en:atypical dose response relationship | rel=r_associated | relid=0 | w=20
  66. en:therapy responder -- r_associated #0: 20 / 0.476 -> en:side effects of drug
    n1=en:therapy responder | n2=en:side effects of drug | rel=r_associated | relid=0 | w=20
  67. en:therapy responder -- r_associated #0: 20 / 0.476 -> en:therapeutic product effective for unapproved indication
    n1=en:therapy responder | n2=en:therapeutic product effective for unapproved indication | rel=r_associated | relid=0 | w=20
  68. en:therapy responder -- r_associated #0: 20 / 0.476 -> événement indésirable
    n1=en:therapy responder | n2=événement indésirable | rel=r_associated | relid=0 | w=20
  69. en:therapy responder -- r_associated #0: 20 / 0.476 -> incident indésirable
    n1=en:therapy responder | n2=incident indésirable | rel=r_associated | relid=0 | w=20
  70. en:therapy responder -- r_associated #0: 20 / 0.476 -> tachyphylaxie
    n1=en:therapy responder | n2=tachyphylaxie | rel=r_associated | relid=0 | w=20
  71. en:therapy responder -- r_associated #0: 20 / 0.476 -> tachyphylaxies
    n1=en:therapy responder | n2=tachyphylaxies | rel=r_associated | relid=0 | w=20
  72. en:therapy responder -- r_associated #0: 1 / 0.024 -> en:finding
    n1=en:therapy responder | n2=en:finding | rel=r_associated | relid=0 | w=1
≈ 81 relations entrantes

  1. en:adverse reaction to drug --- r_associated #0: 459 --> en:therapy responder
    n1=en:adverse reaction to drug | n2=en:therapy responder | rel=r_associated | relid=0 | w=459
  2. effet indésirable d'un médicament --- r_associated #0: 456 --> en:therapy responder
    n1=effet indésirable d'un médicament | n2=en:therapy responder | rel=r_associated | relid=0 | w=456
  3. en:adverse reaction --- r_associated #0: 419 --> en:therapy responder
    n1=en:adverse reaction | n2=en:therapy responder | rel=r_associated | relid=0 | w=419
  4. réaction indésirable --- r_associated #0: 415 --> en:therapy responder
    n1=réaction indésirable | n2=en:therapy responder | rel=r_associated | relid=0 | w=415
  5. tachyphylaxie --- r_associated #0: 126 --> en:therapy responder
    n1=tachyphylaxie | n2=en:therapy responder | rel=r_associated | relid=0 | w=126
  6. en:tachyphylaxis --- r_associated #0: 123 --> en:therapy responder
    n1=en:tachyphylaxis | n2=en:therapy responder | rel=r_associated | relid=0 | w=123
  7. tachyphylaxies --- r_associated #0: 123 --> en:therapy responder
    n1=tachyphylaxies | n2=en:therapy responder | rel=r_associated | relid=0 | w=123
  8. incident indésirable --- r_associated #0: 50 --> en:therapy responder
    n1=incident indésirable | n2=en:therapy responder | rel=r_associated | relid=0 | w=50
  9. en:adverse event --- r_associated #0: 46 --> en:therapy responder
    n1=en:adverse event | n2=en:therapy responder | rel=r_associated | relid=0 | w=46
  10. en:dermal absorption increased --- r_associated #0: 42 --> en:therapy responder
    n1=en:dermal absorption increased | n2=en:therapy responder | rel=r_associated | relid=0 | w=42
  11. événement indésirable --- r_associated #0: 42 --> en:therapy responder
    n1=événement indésirable | n2=en:therapy responder | rel=r_associated | relid=0 | w=42
  12. en:fishbane reaction --- r_associated #0: 39 --> en:therapy responder
    n1=en:fishbane reaction | n2=en:therapy responder | rel=r_associated | relid=0 | w=39
  13. en:renin-angiotensin system inhibition --- r_associated #0: 39 --> en:therapy responder
    n1=en:renin-angiotensin system inhibition | n2=en:therapy responder | rel=r_associated | relid=0 | w=39
  14. en:side effects of drug --- r_associated #0: 38 --> en:therapy responder
    n1=en:side effects of drug | n2=en:therapy responder | rel=r_associated | relid=0 | w=38
  15. en:decreased therapeutic response --- r_associated #0: 35 --> en:therapy responder
    n1=en:decreased therapeutic response | n2=en:therapy responder | rel=r_associated | relid=0 | w=35
  16. en:drug effect variable --- r_associated #0: 35 --> en:therapy responder
    n1=en:drug effect variable | n2=en:therapy responder | rel=r_associated | relid=0 | w=35
  17. en:drug ineffective for unapproved indication --- r_associated #0: 35 --> en:therapy responder
    n1=en:drug ineffective for unapproved indication | n2=en:therapy responder | rel=r_associated | relid=0 | w=35
  18. en:effect, sympathomimetic --- r_associated #0: 35 --> en:therapy responder
    n1=en:effect, sympathomimetic | n2=en:therapy responder | rel=r_associated | relid=0 | w=35
  19. en:therapeutic and nontherapeutic responses --- r_associated #0: 35 --> en:therapy responder
    n1=en:therapeutic and nontherapeutic responses | n2=en:therapy responder | rel=r_associated | relid=0 | w=35
  20. en:therapeutic response unexpected --- r_associated #0: 35 --> en:therapy responder
    n1=en:therapeutic response unexpected | n2=en:therapy responder | rel=r_associated | relid=0 | w=35
  21. en:drug ineffective --- r_associated #0: 34 --> en:therapy responder
    n1=en:drug ineffective | n2=en:therapy responder | rel=r_associated | relid=0 | w=34
  22. en:immediate post-injection reaction --- r_associated #0: 34 --> en:therapy responder
    n1=en:immediate post-injection reaction | n2=en:therapy responder | rel=r_associated | relid=0 | w=34
  23. en:multidrug resistance process --- r_associated #0: 34 --> en:therapy responder
    n1=en:multidrug resistance process | n2=en:therapy responder | rel=r_associated | relid=0 | w=34
  24. en:therapeutic product effective for unapproved indication --- r_associated #0: 34 --> en:therapy responder
    n1=en:therapeutic product effective for unapproved indication | n2=en:therapy responder | rel=r_associated | relid=0 | w=34
  25. en:therapeutic product ineffective for unapproved indication --- r_associated #0: 34 --> en:therapy responder
    n1=en:therapeutic product ineffective for unapproved indication | n2=en:therapy responder | rel=r_associated | relid=0 | w=34
  26. en:therapeutic response changed --- r_associated #0: 34 --> en:therapy responder
    n1=en:therapeutic response changed | n2=en:therapy responder | rel=r_associated | relid=0 | w=34
  27. en:therapy partial responder --- r_associated #0: 34 --> en:therapy responder
    n1=en:therapy partial responder | n2=en:therapy responder | rel=r_associated | relid=0 | w=34
  28. en:drug action decreased --- r_associated #0: 32 --> en:therapy responder
    n1=en:drug action decreased | n2=en:therapy responder | rel=r_associated | relid=0 | w=32
  29. en:drug action prolonged --- r_associated #0: 32 --> en:therapy responder
    n1=en:drug action prolonged | n2=en:therapy responder | rel=r_associated | relid=0 | w=32
  30. en:drug resistance process --- r_associated #0: 32 --> en:therapy responder
    n1=en:drug resistance process | n2=en:therapy responder | rel=r_associated | relid=0 | w=32
  31. en:therapeutic response delayed --- r_associated #0: 32 --> en:therapy responder
    n1=en:therapeutic response delayed | n2=en:therapy responder | rel=r_associated | relid=0 | w=32
  32. répondeur au traitement --- r_associated #0: 32 --> en:therapy responder
    n1=répondeur au traitement | n2=en:therapy responder | rel=r_associated | relid=0 | w=32
  33. en:increased drug tolerance --- r_associated #0: 31 --> en:therapy responder
    n1=en:increased drug tolerance | n2=en:therapy responder | rel=r_associated | relid=0 | w=31
  34. en:no prior therapy --- r_associated #0: 31 --> en:therapy responder
    n1=en:no prior therapy | n2=en:therapy responder | rel=r_associated | relid=0 | w=31
  35. en:positive cardiac inotropic effect --- r_associated #0: 31 --> en:therapy responder
    n1=en:positive cardiac inotropic effect | n2=en:therapy responder | rel=r_associated | relid=0 | w=31
  36. en:treatment failure --- r_associated #0: 31 --> en:therapy responder
    n1=en:treatment failure | n2=en:therapy responder | rel=r_associated | relid=0 | w=31
  37. en:drug intolerance --- r_associated #0: 30 --> en:therapy responder
    n1=en:drug intolerance | n2=en:therapy responder | rel=r_associated | relid=0 | w=30
  38. en:prolonged therapeutic response --- r_associated #0: 30 --> en:therapy responder
    n1=en:prolonged therapeutic response | n2=en:therapy responder | rel=r_associated | relid=0 | w=30
  39. en:shortened therapeutic response --- r_associated #0: 30 --> en:therapy responder
    n1=en:shortened therapeutic response | n2=en:therapy responder | rel=r_associated | relid=0 | w=30
  40. en:vaccine positive rechallenge --- r_associated #0: 30 --> en:therapy responder
    n1=en:vaccine positive rechallenge | n2=en:therapy responder | rel=r_associated | relid=0 | w=30
  41. en:decreased drug tolerance --- r_associated #0: 29 --> en:therapy responder
    n1=en:decreased drug tolerance | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  42. en:enzyme inhibition disorder --- r_associated #0: 29 --> en:therapy responder
    n1=en:enzyme inhibition disorder | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  43. en:insulin sparing effect --- r_associated #0: 29 --> en:therapy responder
    n1=en:insulin sparing effect | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  44. en:no reaction on previous exposure to drug --- r_associated #0: 29 --> en:therapy responder
    n1=en:no reaction on previous exposure to drug | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  45. en:reactogenicity event --- r_associated #0: 29 --> en:therapy responder
    n1=en:reactogenicity event | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  46. en:remission not achieved --- r_associated #0: 29 --> en:therapy responder
    n1=en:remission not achieved | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  47. en:similar reaction on previous exposure to drug --- r_associated #0: 29 --> en:therapy responder
    n1=en:similar reaction on previous exposure to drug | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  48. en:surgical failure --- r_associated #0: 29 --> en:therapy responder
    n1=en:surgical failure | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  49. en:therapeutic product ineffective --- r_associated #0: 29 --> en:therapy responder
    n1=en:therapeutic product ineffective | n2=en:therapy responder | rel=r_associated | relid=0 | w=29
  50. Besredka (méthode de) --- r_associated #0: 28 --> en:therapy responder
    n1=Besredka (méthode de) | n2=en:therapy responder | rel=r_associated | relid=0 | w=28
  51. en:adverse reaction to food --- r_associated #0: 28 --> en:therapy responder
    n1=en:adverse reaction to food | n2=en:therapy responder | rel=r_associated | relid=0 | w=28
  52. en:diet failure --- r_associated #0: 28 --> en:therapy responder
    n1=en:diet failure | n2=en:therapy responder | rel=r_associated | relid=0 | w=28
  53. en:drug action increased --- r_associated #0: 28 --> en:therapy responder
    n1=en:drug action increased | n2=en:therapy responder | rel=r_associated | relid=0 | w=28
  54. en:drug effect incomplete --- r_associated #0: 28 --> en:therapy responder
    n1=en:drug effect incomplete | n2=en:therapy responder | rel=r_associated | relid=0 | w=28
  55. en:drug tolerance --- r_associated #0: 28 --> en:therapy responder
    n1=en:drug tolerance | n2=en:therapy responder | rel=r_associated | relid=0 | w=28
  56. en:therapy non-responder --- r_associated #0: 28 --> en:therapy responder
    n1=en:therapy non-responder | n2=en:therapy responder | rel=r_associated | relid=0 | w=28
  57. en:drug cross-reactivity --- r_associated #0: 27 --> en:therapy responder
    n1=en:drug cross-reactivity | n2=en:therapy responder | rel=r_associated | relid=0 | w=27
  58. en:drug effect delayed --- r_associated #0: 27 --> en:therapy responder
    n1=en:drug effect delayed | n2=en:therapy responder | rel=r_associated | relid=0 | w=27
  59. en:idiosyncratic drug effect --- r_associated #0: 27 --> en:therapy responder
    n1=en:idiosyncratic drug effect | n2=en:therapy responder | rel=r_associated | relid=0 | w=27
  60. en:negative cardiac inotropic effect --- r_associated #0: 27 --> en:therapy responder
    n1=en:negative cardiac inotropic effect | n2=en:therapy responder | rel=r_associated | relid=0 | w=27
  61. en:atypical dose response relationship --- r_associated #0: 26 --> en:therapy responder
    n1=en:atypical dose response relationship | n2=en:therapy responder | rel=r_associated | relid=0 | w=26
  62. en:dermal absorption impaired --- r_associated #0: 26 --> en:therapy responder
    n1=en:dermal absorption impaired | n2=en:therapy responder | rel=r_associated | relid=0 | w=26
  63. en:drug effect faster than expected --- r_associated #0: 26 --> en:therapy responder
    n1=en:drug effect faster than expected | n2=en:therapy responder | rel=r_associated | relid=0 | w=26
  64. en:increased therapeutic response --- r_associated #0: 26 --> en:therapy responder
    n1=en:increased therapeutic response | n2=en:therapy responder | rel=r_associated | relid=0 | w=26
  65. en:paradoxical drug reaction --- r_associated #0: 26 --> en:therapy responder
    n1=en:paradoxical drug reaction | n2=en:therapy responder | rel=r_associated | relid=0 | w=26
  66. en:reaction time decreased --- r_associated #0: 26 --> en:therapy responder
    n1=en:reaction time decreased | n2=en:therapy responder | rel=r_associated | relid=0 | w=26
  67. en:virologic failure --- r_associated #0: 26 --> en:therapy responder
    n1=en:virologic failure | n2=en:therapy responder | rel=r_associated | relid=0 | w=26
  68. évènement indésirable --- r_associated #0: 23 --> en:therapy responder
    n1=évènement indésirable | n2=en:therapy responder | rel=r_associated | relid=0 | w=23
  69. en:enzyme induction --- r_associated #0: 22 --> en:therapy responder
    n1=en:enzyme induction | n2=en:therapy responder | rel=r_associated | relid=0 | w=22
  70. effet indésirable --- r_associated #0: 21 --> en:therapy responder
    n1=effet indésirable | n2=en:therapy responder | rel=r_associated | relid=0 | w=21
  71. en:adverse event following immunization --- r_associated #0: 21 --> en:therapy responder
    n1=en:adverse event following immunization | n2=en:therapy responder | rel=r_associated | relid=0 | w=21
  72. intolérance médicamenteuse --- r_associated #0: 21 --> en:therapy responder
    n1=intolérance médicamenteuse | n2=en:therapy responder | rel=r_associated | relid=0 | w=21
  73. thérapie --- r_associated #0: 20 --> en:therapy responder
    n1=thérapie | n2=en:therapy responder | rel=r_associated | relid=0 | w=20
  74. effet de souffle (lésion par) --- r_associated #0: 15 --> en:therapy responder
    n1=effet de souffle (lésion par) | n2=en:therapy responder | rel=r_associated | relid=0 | w=15
  75. Événement indésirable --- r_associated #0: 15 --> en:therapy responder
    n1=Événement indésirable | n2=en:therapy responder | rel=r_associated | relid=0 | w=15
  76. Effet indésirable --- r_associated #0: 10 --> en:therapy responder
    n1=Effet indésirable | n2=en:therapy responder | rel=r_associated | relid=0 | w=10
  77. en:lesion by blast effect --- r_associated #0: 10 --> en:therapy responder
    n1=en:lesion by blast effect | n2=en:therapy responder | rel=r_associated | relid=0 | w=10
  78. en:undesirable event --- r_associated #0: 10 --> en:therapy responder
    n1=en:undesirable event | n2=en:therapy responder | rel=r_associated | relid=0 | w=10
  79. effet Hamburger --- r_associated #0: 5 --> en:therapy responder
    n1=effet Hamburger | n2=en:therapy responder | rel=r_associated | relid=0 | w=5
  80. effet indésirable d'un dispositif médical --- r_associated #0: 5 --> en:therapy responder
    n1=effet indésirable d'un dispositif médical | n2=en:therapy responder | rel=r_associated | relid=0 | w=5
  81. évacuation(clichéen) --- r_associated #0: 5 --> en:therapy responder
    n1=évacuation(clichéen) | n2=en:therapy responder | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr